Cart
sales@molnova.com
Orilotimod potassium
CAS No. 960155-19-5
Orilotimod potassium( —— )
Catalog No. M36132 CAS No. 960155-19-5
Orilotimod potassium (APO805K1) can be used to study plaque psoriasis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 120 | In Stock |
|
| 10MG | 177 | In Stock |
|
| 25MG | 334 | In Stock |
|
| 50MG | 440 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOrilotimod potassium
-
NoteResearch use only, not for human use.
-
Brief DescriptionOrilotimod potassium (APO805K1) can be used to study plaque psoriasis.
-
DescriptionOrilotimod potassium (APO805K1) can be used to study plaque psoriasis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number960155-19-5
-
Formula Weight371.43
-
Molecular FormulaC16H18KN3O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC([C@H](N)CCC(N[C@@H](C([O-])=O)CC1=CNC2=CC=CC=C12)=O)=O.[K+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Neurotensin(8-13) 3T...
Neurotensin(8-13)(3TFA) is?Neurotensin (NT)?fragment, Neurotensin(8-13) results in a decrease in cell-surface NT1 receptors (NTR1) density.The internalization of the receptor induced by neurotensin (8-13) leads to a decrease in the density of the NT1 receptor (NTR1) on the cell surface.
-
KKI-5
KKI 5 is a serine protease inhibitor that inhibits kallikrein and plasmin. KKI 5 may exhibit anticancer chemotherapeutic benefit and may also be used as a treatment for angioedema.
-
VPC-18005
VPC-18005 is a luciferase inhibitor. VPC-18005 inhibits ERG-induced transcription and interacts directly with the ERG-ETS domain thereby disrupting the ERG binding to DNA.
